Metropolis Healthcare Past Earnings Performance
Past criteria checks 2/6
Metropolis Healthcare has been growing earnings at an average annual rate of 3.6%, while the Healthcare industry saw earnings growing at 29.7% annually. Revenues have been growing at an average rate of 9.9% per year. Metropolis Healthcare's return on equity is 12%, and it has net margins of 10.8%.
Key information
3.6%
Earnings growth rate
3.1%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 9.9% |
| Return on equity | 12.0% |
| Net Margin | 10.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09
Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 10Metropolis Healthcare (NSE:METROPOLIS) Knows How to Allocate Capital
Dec 26The Metropolis Healthcare (NSE:METROPOLIS) Share Price Is Up 54% And Shareholders Are Holding On
Dec 11Revenue & Expenses BreakdownBeta
How Metropolis Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 11,593 | 1,248 | 3,889 | 77 |
| 30 Sep 23 | 11,536 | 1,334 | 3,840 | 75 |
| 30 Jun 23 | 11,454 | 1,383 | 3,758 | 63 |
| 31 Mar 23 | 11,482 | 1,429 | 3,730 | 66 |
| 31 Dec 22 | 11,716 | 1,495 | 3,806 | 77 |
| 30 Sep 22 | 11,792 | 1,548 | 3,785 | 78 |
| 30 Jun 22 | 11,814 | 1,727 | 3,688 | 76 |
| 31 Mar 22 | 12,283 | 2,142 | 3,649 | 69 |
| 31 Dec 21 | 12,142 | 2,355 | 2,995 | 71 |
| 30 Sep 21 | 11,959 | 2,531 | 2,899 | 60 |
| 30 Jun 21 | 11,816 | 2,551 | 2,865 | 54 |
| 31 Mar 21 | 9,980 | 1,831 | 2,746 | 54 |
| 31 Dec 20 | 9,132 | 1,372 | 2,590 | 64 |
| 30 Sep 20 | 8,613 | 1,207 | 2,545 | 67 |
| 30 Jun 20 | 7,962 | 1,034 | 1,890 | 73 |
| 31 Mar 20 | 8,564 | 1,273 | 2,567 | 69 |
| 31 Dec 19 | 8,513 | 1,463 | 2,601 | 60 |
| 30 Sep 19 | 8,189 | 1,355 | 2,563 | 60 |
| 30 Jun 19 | 7,887 | 1,230 | 2,544 | 57 |
| 31 Mar 19 | 7,612 | 1,201 | 2,486 | 56 |
| 31 Mar 18 | 6,472 | 1,042 | 2,008 | 57 |
| 31 Mar 17 | 5,447 | 1,017 | 1,658 | 25 |
| 31 Mar 16 | 4,755 | 768 | 1,388 | 31 |
| 31 Mar 15 | 4,555 | 610 | 1,181 | 37 |
| 31 Mar 14 | 3,883 | 566 | 932 | 35 |
Quality Earnings: METROPOLIS has high quality earnings.
Growing Profit Margin: METROPOLIS's current net profit margins (10.8%) are lower than last year (12.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: METROPOLIS's earnings have grown by 3.6% per year over the past 5 years.
Accelerating Growth: METROPOLIS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: METROPOLIS had negative earnings growth (-16.6%) over the past year, making it difficult to compare to the Healthcare industry average (28%).
Return on Equity
High ROE: METROPOLIS's Return on Equity (12%) is considered low.